Actively Recruiting
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
Led by Antonios Likourezos · Updated on 2025-06-04
150
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In situations where intravenous access is not readily available or is unobtainable and the intranasal route is not feasible, another non-invasive route of ketamine administration, such as inhalation via breath-actuated Nebulizer (BAN), is becoming a viable alternative. The BAN allows the controlled, patient-initiated delivery of analgesics in a measured and titratable fashion. (18) Ketamine has been studied as a nebulized drug in a lot of different settings and for a lot of different reasons, such as to treat acute pain after surgery (like a sore throat after being intubated), as a pre-medication for general anesthesia, to treat cancer pain, and as a therapy for asthmaticus. Our research team has published two case series of 10 adult patients who were given nebulized ketamine (via BAN) for a variety of acute traumatic and non-traumatic painful conditions. The patients showed a 60% decrease in pain and a small number of side effects. Furthermore, our group published a randomized, double-blind trial of 120 adult patients evaluating the analgesic efficacy and safety of nebulized ketamine at three different dosing regimens for acute pain in the ED (0.75 mg/kg, 1 mg/kg, and 1.5 mg/kg), showing similar analgesic efficacy between the three different dosing regimens for short-term (up to 120 minutes) pain relief. Lastly, we recently completed a randomized, double-blind, double-dummy clinical trial comparing the analgesic efficacy and safety of nebulized ketamine and intravenous ketamine in managing acute pain in adult ED patients, with data currently being analyzed. Nebulized fentanyl given in the ED to adults with acute traumatic and non-traumatic pain syndromes at a dose range of 1.5-4 mcg/kg showed the same or even better pain-relieving effects than IV fentanyl and IV morphine alone. Our objective is to compare the analgesic efficacy and rates of side effects of a 0.75 mg/kg dose of ketamine administered via breath-actuated nebulizer (BAN) to a dose of 3 mcg/kg of fentanyl administered via breath-actuated nebulizer (BAN) in adult patients presenting to the ED with acute painful conditions.
CONDITIONS
Official Title
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Acute painful condition
- Pain score of 5 or more on an 11-point numeric rating scale
- Patient is awake, alert, and oriented to person, place, and time
- Patient understands the informed consent process and content
- Patient can describe any side effects experienced
- Patient can express their pain severity using the numeric rating scale
You will not qualify if you...
- Painful condition requiring urgent or emergency intervention in the ED
- Altered mental status
- Allergy to ketamine or fentanyl
- Pregnant or breastfeeding
- Weight over 100 kg
- Presenting with head injury
- Unstable vital signs (systolic blood pressure <90 or >180 mmHg, pulse rate <50 or >150 beats/min, respiration rate <10 or >30 breaths/min)
- Unable to provide consent
- History of alcohol or drug abuse
- Use of opioids or opioid antagonist/agonist within 4-6 hours before arrival
- Use of NSAIDs within 6 hours before arrival
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219
Actively Recruiting
Research Team
A
Antonios Likourezos, MA, MPH
CONTACT
S
Sergey Motov, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here